Indapamida Gp

Indapamide, the active ingredient in Indapamida Gp, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower elevated blood pressure and to reduce fluid accumulation in patients with heart‑related edema.

GNH USA supplies Indapamida Gp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is a thiazide‑like diuretic used in the management of conditions involving excess fluid or elevated vascular resistance.

- Hypertension: lowers systolic and diastolic blood pressure, helping to reduce cardiovascular risk. - Edema associated with congestive heart failure: promotes urinary excretion of sodium and water, decreasing fluid overload. - Primary hypertension: provides long‑term blood pressure control as part of a comprehensive antihypertensive regimen.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Increased frequency of urination - Headache - Nausea or mild gastrointestinal upset

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Allergic reactions such as rash, pruritus, or angioedema - Marked hypotension leading to syncope

Before initiating therapy, clinicians should consider several safety measures.

- Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: evaluate creatinine clearance prior to use and during treatment. - Use caution in gout: thiazide‑like agents can increase serum uric acid. - Avoid in severe hepatic impairment: impaired metabolism may increase drug exposure. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Indapamide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Lithium: risk of lithium toxicity may increase. - NSAIDs: may reduce diuretic effectiveness and impair renal function. - Digoxin: enhanced serum digoxin concentrations can occur.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: hypoglycaemia risk may rise, requiring dose adjustment. - Other antihypertensives: additive blood‑pressure‑lowering effect may cause hypotension. - Corticosteroids: may exacerbate potassium loss, necessitating electrolyte monitoring.